Key Developments: Tianyin Pharmaceutical Inc Co (TPI)
0.60USD
23 May 2013
$-0.01 (-1.64%)
$0.61
$0.61
$0.61
$0.60
12,100
17,474
$0.88
$0.25
Latest Key Developments (Source: Significant Developments)
Tianyin Pharmaceutical Co Inc Reiterates FY 2013 Revenue Guidance
Tianyin Pharmaceutical Co Inc reiterated its fiscal 2013 revenue projection of approximately $75 million to $80 million. Full Article
Tianyin Pharmaceutical Co Inc Lowers FY 2012 Guidance
Tianyin Pharmaceutical Co Inc revised its fiscal 2012 revenue guidance from $100 million to $66 million and net income guidance from $10 million to $6.5 million. Full Article
Tianyin Pharmaceutical Co Inc Issues FY 2012 Guidance
Tianyin Pharmaceutical Co Inc announced that for fiscal 2012, it expects revenue of $100 million and net income guidance of $11 million. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
